Clinical Trial: Study of IPG1094 Tablets in Chinese Healthy Adults and Obese Adults

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935291) titled 'Study of IPG1094 Tablets in Chinese Healthy Adults and Obese Adults' on Oct. 28.

Brief Summary: This is a Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary weight-loss effect of IPG1094 tablets. The study includes three parts: Part A is single ascending dose in healthy volunteers; Part B is multiple ascending dose in healthy volunteers; Part C is multiple-dose exploration in obese adult participants. Subjects will be randomly assigned to receive IPG1094 or matching placebo. Safety, blood drug concentration and weight-related indicators will be followed up.

Study Start Date: Nov. 25

Study...